Figure 5From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancerTime-dependent inhibition of NF-κB activity by DHMEQ. T24PR cells were incubated with or without 10 μg/ml of DHMEQ for various times and then the nuclear extract was assayed by EMSA.Back to article page